Bromfenac Sodium Sesquihydrate is a nonsteroidal anti-inflammatory drug (NSAID) primarily utilized in ophthalmology to treat postoperative ocular inflammation and pain. By inhibiting cyclooxygenase enzymes,… Read more
Bromfenac Sodium Sesquihydrate is a nonsteroidal anti-inflammatory drug (NSAID) primarily utilized in ophthalmology to treat postoperative ocular inflammation and pain. By inhibiting cyclooxygenase enzymes, this medication reduces prostaglandin synthesis within the eye, providing effective symptom relief. The Bromfenac Sodium Sesquihydrate category provides analytical laboratories and pharmaceutical manufacturers with essential reference standards for the active pharmaceutical ingredient (API), alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for accurate impurity profiling, method development, and rigorous quality control protocols. Chemists and researchers rely on these reference materials to validate analytical methods, ensuring precise quantification and characterization of related substances and degradants in accordance with regulatory requirements for ophthalmic drug manufacturing.